TRANSVAC-DS: Towards a sustainable European vaccine infrastructure

The NIBSC works to support the design and establishment of a sustainable European vaccine infrastructure as part of a Horizon 2020 EC-funded project.

TRANSVAC-DS, which officially started on 01 June 2020, is being coordinated by the European Vaccine Initiative and involves a consortium of 25 partner organisations from across eleven countries.

TRANSVAC-DS builds on the successes of TRANSVAC1 and TRANSVAC2 projects (www.transvac.org), and the ultimate goal is the establishment of a truly sustainable pan-European Research Infrastructure bringing together leading European scientific expert groups with their state-of-the-art resources that will accelerate the development of safe, effective and affordable vaccines for global public health.

A leaflet is available with further information.

The NIBSC contributes in several work packages involving ‘gaps and needs’ analysis of the research infrastructure landscape, stakeholder engagement and establishment of a suitable business model. We are co-leading with the work focused on the identification of potential ethical issues that could arise from a future sustainable Research Infrastructure and developing guidance document to ensure compliance with regulations.   
Further information about TRANSVAC-DS is available here. https://www.transvac.org/transvac-ds